For purposes of gene therapy, the tropism of adenovirus (Ad) serotype 5 vectors can be altered with fibers derived from alternative serotypes. However, there is currently limited information available on the cellular receptors used by the approximately 51 known Ad serotypes. Recently, a(2!3)-linked sialic acid (2,3-SA) has been implicated as the cellular receptor for wild-type Ad37. However, some studies have demonstrated that wild-type Ad37 uses a 50-kDa protein and not sialic acid as its primary receptor for binding of human conjunctival cells. The sialic acid receptor has also been shown not to play a major role in the infection of these cells by an Ad5 virion pseudotyped with Ad37 fiber (Ad5.GFP.DF/37F). In this study, we demonstrate that a similar virus (Ad5F37) can indeed use a(2!3)-linked sialic acid as a cellular receptor. We also find that the receptor used by Ad5F37 is sensitive to proteases and that Ad5F37 can use integrin more efficiently than sialic acid for cell entry. Unlike Ad5 vectors, Ad5F37 does not efficiently employ the coxsackie and adenovirus receptor (CAR) to infect cells. Similar to Ad5, Ad5F37 infection of cells that form tight junctions can be enhanced by ethylenediaminetetraacetic acid (EDTA). These results have implications in the design of pseudotyped adenovirus vectors for gene therapy and may have particular use in the treatment of diseases involving breakdown of the blood -retinal barrier.
Introduction
Adenovirus (Ad) is the vector of choice in many gene therapy applications. The majority of gene therapy studies utilizing Ad have used serotypes 2 and 5. The tropism of both of these Ads is determined by the binding of the knob domain of the fiber protein to the coxsackie virus and adenovirus receptor (CAR) (Bergelson et al., 1997) , a transmembrane protein of the tight junction (Cohen et al., 2001) . Intravenous injection of recombinant Ad2 or Ad5 in rodents results in rapid uptake by the liver (Alemany and Curiel, 2001) , and ablation of CAR binding is generally insufficient to alter Ad tropism (Einfeld et al., 2001) . To enhance the utility of Ad in gene therapy applications, there has been considerable interest in redirecting Ad5 tropism by pseudotyping Ad5 with fibers from Ads of alternative serotypes (Einfeld and Roelvink, 2002) . However, little is known about the cellular receptors used by the approximately 51 other known Ad serotypes (De Jong et al., 1999; Shenk, 1995) . Recently, it has been shown that certain group D viruses including Ad37 use sialic acid as a cellular receptor to gain entry into a variety of cell types including ovarian (CHO), lung epithelial (A549), and human conjunctival (Chang C), and that the sialic acid binding is mediated by the knob domain of the fiber (Arnberg et al., 2000a (Arnberg et al., , 2000b (Arnberg et al., , 2002 . In contrast, some studies have determined that wild-type Ad37 binds Chang C cells using a neuraminidase-insensitive 50-kDa membrane protein and that an Ad5 virus pseudotyped with an Ad37 fiber (Ad5.GFP.DF/37F) infects Chang C cells using a sialic acid-independent pathway. These same authors also determined that cell and tissue tropism of Ad5.GFP.DF/37F vectors is substantially altered relative to Ad5 viruses . In the context of gene therapy, the issue of which receptor is utilized by a pseudotyped Ad5F37 is of significant interest. The majority of previous studies where the tropism of pseudotyped Ad vectors was studied were done without information on the receptor being utilized by the virus, resulting in important gaps in our knowledge on the behavior of pseudotyped Ad vectors. Identification of sialic acid as a potential receptor for Ad37 allows for better characterization of the altered tropism of Ads pseudotyped by Ad37 fibers. In contrast to previously published studies, here we show that akin to Ad37, Ad5F37 also uses a(2!3)-linked sialic acid (2,3-SA) as a cellular receptor. Infection of cells by Ad5F37 is sensitive to proteases and Ad5F37 can use integrin alone to infect cells more efficiently than a(2!3)-linked sialic acid alone. Similar to wild-type Ad37, Ad5F37 does not use CAR for infection of cells. Finally, we show that like Ad5, Ad5F37 infection of cells that form tight junctions can be enhanced by ethylenediaminetetraacetic acid (EDTA).
Results

Pseudotyping of Ad5 with Ad37 fiber
To determine whether Ad5 tropism could be redirected from CAR to sialic acid, we modified the Ad5 genome ( Fig. 1A ) cloned in pAdEasy1 (He et al., 1998) such that the gene encoding Ad5 fiber was instead expressing a fusion fiber consisting of the N terminal 10 amino acids unique to Ad5 fiber, followed by the amino acids FNPVYPY that are common to both Ad5 and Ad37 fiber (amino acids 11 -17 of Ad5 or Ad37 fiber), followed by amino acids 18 -365 of Ad37 fiber (Fig.  1B) . The 'fusion' fiber was polyadenylated by a BGH pA signal in addition to the native Ad5 fiber poly A signal, which was retained to ensure a potent pA signal downstream of the fusion fiber in addition to reducing the possibility of deleteriously affecting any transcripts on the antisense strand. To examine cell entry and expression of viral genes, an expression cassette encoding enhanced GFP (EGFP) regulated by a cytomegalovirus (CMV) promoter was inserted into the (deleted) E1 region of the pseudotyped virus EGFPNAd5F37. A similar expression cassette was cloned into the parental control Ad5 virus EGFPNAd5 (Fig. 1A) . To confirm expression and translation of the fusion fiber, we infected 911 cells with each virus and probed the fiber protein using a monoclonal antibody generated against the N-terminal region of Ad2 -Ad5. As predicted by sequence analysis, we observed protein products consistent with denatured wild-type Ad5 fiber of 65 kDa in cells infected with EGFPNAd5 and a shorter 40-kDa product consistent with the predicted amino acid sequence of the EGFPNAd5F37 fiber. Trimerization (and dimerization in the case of EGFPNAd5) of fibers from each virus was also detected in samples that were not boiled before Western analysis (Fig. 1C) . Expression of EGFP from the transgene of each virus was confirmed by infection of 911 cells and visualization using a GFP fluorescence microscope (data not shown). . The hybrid fiber is composed of the first 10 amino acids of Ad5 followed by amino acids 11 -365 of wild-type Ad37 (aa 11 -17 of Ad5 and Ad37 are identical). The fusion fiber is followed by 63 bp of Ad37 DNA containing a poly A signal that is further followed by a bovine growth hormone polyadenylation signal (BGH pA). Ad5 nucleotides 32 744 -32 787 were retained to ensure proper functioning of the E4 genes. An EGFP expression cassette was cloned in the antisense orientation (with respect to the E1 enhancer) into the E1 region of an E1lE3-deleted Ad5 virus. N terminal amino acid sequence of wild-type Ad5, wild-type Ad37, and the fusion fiber of EGFPNAd5f37 (B). Western analysis of denatured and native fiber proteins from EGFPNAd5 (expected products 65, 130, and 195 KDa for monomer, dimer, and trimer, respectively) and EGFPNAd5F37 (expected products 40 and 120 kDa for monomer and trimer, respectively) using a monoclonal antibody specific for the N-terminal amino acids of Ad2 -Ad5 (C). ITR, adenovirus inverted terminal repeat; C, Ad packaging signal; MLT, major late transcription unit; E, early region; CMV, cytomegalovirus promoter/enhancer.
EGFPNAd5F37 uses a(2!3)-linked sialic acid for infection
In some previous studies, wild-type Ad37 was shown to specifically bind a(2!3)-linked sialic acid (2,3-SA) (Arnberg et al., 2000a) . Sialic acid was shown to be involved in Ad37 entry by observing that pretreatment of Chang C or A549 cells with Vibrio cholerae neuraminidase significantly reduces wild-type Ad37 binding (Arnberg et al., 2000b (Arnberg et al., , 2002 . In addition, Ad37 binding can be significantly reduced by pre-incubation of cells with the 2,3-SA binding maackia amurensis lectin Mal II (Arnberg et al., 2000a) . To determine if EGFPNAd5F37 can also use sialic acid as a cellular receptor, we investigated infection of Chang C and A549 cells by EGFPNAd5F37 or EGFPNAd5. Before infection, we first confirmed that both cell types were expressing 2,3-SA by measuring their ability to bind Mal II ( Fig. 2A) . We then blocked cell surface 2,3-SA with Mal II or removed sialic acid by exposure of cells to Vibrio cholerae neuraminidase before infection with each virus. We found that whereas prior exposure of Chang C or A549 cells to neuraminidase had no significant effect on EGFPNAd5 infection, EGFPNAd5F37 infection was reduced by 60 F 0.5% and 37 F 1.2% in Chang C and A549 cells, respectively. Similarly, prior treatment of cells with Mal II had no significant effect on EGFPNAd5 infection, whereas infection by EGFPNAd5F37 was reduced by 26 F 3.6% and 60 F 3.2% in Chang C and A549 cells, respectively (Fig. 2B) . Of note is that Wu et al. (2001) observed an approximately 16-fold greater infection of Chang C cells relative to A549 by a virus very similar to EGFPNAd5F37, whereas we found a difference of approximately 1.2-to 1.4-fold greater infection of A549 relative to Chang C (Fig. 2B) . Nonetheless, our results are consistent with the hypothesis that EGFPNAd5F37 uses 2,3-SA as a cellular receptor because these two cell lines have comparable amounts of sialic acid ( Fig. 2A ).
EGFPNAd5f37 receptor is sensitive to proteases
Previously, it has been shown that wild-type Ad37 binding of Chang C ) and CHO cells (Arnberg et al., 2000a ) is reduced when those cells are pretreated with general or specific proteases. To determine if this property is also conferred upon EGFPNAd5F37, we infected Chang C or A549 cells that had been pretreated with the broad spectrum (Ebeling et al., 1974) serine protease, Proteinase K, or the more specific (Rowan et al., 1990 ) cysteine protease Bromelain. Similar to previous results obtained with wild-type Ad37, EGFPNAd5F37 had reduced infectivity of cells that had been pretreated with either protease (Fig. 3) , although the effect, at least for Bromelain, was more significant in Chang C than A549 cells ( P < 0.03). In addition, infection by EGFPNAd5F37 was more significantly reduced relative to that of EGFPNAd5. Specifically, the control virus EGFPNAd5 that is known to bind the transmembrane receptor protein CAR was reduced by 36.6 F 0.6% and 26.4 F 1.3% in Chang C and A549 cells, respectively, with Proteinase K treatment and 19.9 F 5.4% and 5.9 F 1.8% in Chang C and A549 cells, respectively, with Bromelain. In contrast, EGFPNAd5F37 was reduced by 50 F 1.4% and 38.2 F 2.3% in Chang C and A549 cells, respectively, with Proteinase K treatment and 26.8 F 1.8% and 10 F 2.5% in Chang C and A549 cells, respectively, with Bromelain ( Fig. 3) . These data are consistent with the hypothesis that the sialic acid used by EGFPNAd5F37 is present on glycoproteins as previously shown for wild-type Ad37 (Arnberg et al., 2000a) .
Role of CAR, integrin, and sialic acid in EGFPNAd5F37 and EGFPNAd5 infection
Ablation of either CAR or integrin binding by Ad5 has been previously shown to reduce infectivity of AE25 cells 10-fold (Einfeld et al., 2001) . The biodistribution of an intravenously injected Ad is not significantly affected by ablation of CAR binding, and more than 75% of the remaining infectivity has been attributed to the penton base: integrin interaction (Alemany and Curiel, 2001) . Many different Ad serotypes use aV integrins for cell entry via receptor-mediated endocytosis following attachment to their receptor (Mathias et al., 1994) . A role for aV integrin has been implicated in infection by Ad37 (Arnberg et al., 2000b) , and it has been shown that Ad37 binds aVh5 integrin with an approximately 2-fold greater efficiency than Ad5 (Mathias et al., 1998) , possibly indicating that Ad37 can use integrin more efficiently for cellular uptake than Ad5. In addition, Ad5.GFP.DF/37F infection of Chang C cells can be reduced approximately 2.8-fold if the cells are pretreated with an aV integrin-blocking antibody (Chiu et al., 2001) . To generally examine the relative role of aV integrin in EGFPNAd5F37 and EGFPNAd5 infection, we determined aV expression in five different cell lines. Specifically, we tested Chang C, A549, RPE-J, Y79, and CHO (Lec2). All cell lines except the retinoblastoma cell line Y79 were determined to express aV integrin (Fig. 4A ). Y79 cells did however express 2,3-SA (Fig. 4B) . To determine the relative efficiencies of EGFPNAd5F37 and EGFPNAd5 for their primary receptors, 2,3-SA and CAR, respectively, we used the CHO subline, Lec2. Lec2 has previously been shown to express a reduced amount of sialic acid by measuring its ability to bind wheat germ agglutinin (WGA) (Arnberg et al., 2000a) . We examined whether cell surface 2,3-SA was specifically reduced on Lec2 and Y79 cells by measuring binding of Mal II (Fig. 4B ) by these cells. We also determined the expression of CAR on these cells by flow cytometry. We found that Lec 2 cells did not express significant amounts of CAR, but Y79 cells did express CAR (Fig. 4D ). Because we determined that Lec 2 cells do express aV integrin but not CAR or 2,3-SA, we were able to utilize these cells to determine the relative efficiencies of EGFPNAd5F37 and EGFPNAd5 for their primary receptors. We found that EGFPNAd5 infects both Y79 and Lec2 cells more efficiently (at least 50-and 35-fold, respectively) than EGFPNAd5F37 (Fig. 4C) , consistent with the more efficient use of both moieties by this virus. A multiplicity of infection (MOI) of 48 000 (4-fold higher than that used in Lec2 cells) resulted in observable infection of Y79 cells, indicating the ability of EGFPNAd5F37 to use sialic acid alone to infect cells albeit much less efficiently than integrin alone. These data are also consistent with the hypothesis that in the case of EGFPNAd5, CAR plays a greater role than aV integrin in cell entry. However, as EGFPNAd5 does infect CARdeficient Lec 2 cells, the role of CAR relative to aV integrin should not be overstated.
EGFPNAd5F37 cannot use CAR to efficiently infect cells
Previously, it has been shown that the knob domain of wild-type Ad37 fiber can bind CAR ). In addition, the Ad5 fiber knob significantly blocks Ad37 binding to A549 cells, raising the possibility that these viruses may share cellular receptors (Wu et al., 2003) . Ad37 fiber has a sequence similar to the CAR-binding site of Ad5 fiber (Bewley et al., 1999) . CAR has also been shown to be efficiently used by an Ad2 virus pseudotyped with the subgenus D, Ad17 fiber (Zabner et al., 1999) . Given that wild-type Ad37 fiber can bind CAR, we wished to determine whether EGFPNAd5F37 might also potentially use CAR as a cellular receptor. CHO cells lack significant expression of CAR (Shayakhmetov et al., 2000) , which we confirmed also true for the CHO subline Lec2 (Fig. 4B) . When CHO cells are stably transfected with a plasmid expressing CAR, Ad5 binding increases approximately 24-fold (Arnberg et al., 2000a) . Because Lec 2 cells also do not express CAR, we examined the ability of EGFPNAd5F37 to infect Lec 2 cells that had been transfected with a plasmid expressing human CAR (hCAR). Using electroporation, we were able to consistently transfect 40% of Lec 2 cells with either a plasmid expressing LacZ or CAR (data not shown). Under these conditions, we found that EGFPNAd5 infection was not only increased by 13.3 F 0.96% in cells transiently transfected with CAR relative to LacZ (Fig. 5B) , but also that EGFPNAd5-infected CAR-expressing cells had a 2.4-fold increase in GFP (Figs. 5A and 5C) expression. Although the number of CAR-transfected cells infected by EGFPNAd5F37 increased by 5.6 F 1.39% (Fig. 5B) relative to LacZ-transfected cells, these cells showed no increase in levels of GFP 
EDTA enhances infection of RPE-J cells by EGFPNAd5F37
Disruption of tight junctions with EDTA has been previously shown to enhance infection of polarized tracheobronchial epithelial cells by recombinant Ad5 viruses by increasing accessibility of CAR sequestered in these junctions (Cohen et al., 2001) . The retinal pigment epithelium is involved in the formation and maintenance of the outer blood -retinal barrier (Cunha-Vaz, 1979) . RPE-J is a rat retinal pigment epithelial cell line that exhibits cell surface polarity in vitro, as well as circumferential staining for the tight junction protein, ZO-1 (Nabi et al., 1993) . We confirmed the expression of 2,3-SA, aV integrin, and CAR by RPE-J cells (Figs. 4A and 6A ). In addition, we observed the sialic acid-binding lectin wheat germ agglutinin (WGA) to stain predominantly at points of cell to cell contact (Fig. 6B) , similar to previously reported expression patterns for ZO-1 and CAR (Cohen et al., 2001) . We tested the ability of EGFPNAd5F37 and EGFPNAd5 to infect RPE-J cells that had their tight junctions disrupted by EDTA. We determined that use of 2.5 mM EDTA was sufficient to observe an increase in infection of 61.4 F 1.1% and 50.9 F 7.0% by EGFPNAd5F37 and EGFPNAd5, respectively (Fig. 6C) . In previous studies, pretreatment of Chang C cells with 10 mM EDTA has been shown to completely ablate binding by wild-type Ad37 . However, in some other studies, the same concentration of EDTA has been reported to have no effect on binding of wild-type Ad37 (Arnberg et al., 2002) .
Discussion
Our studies are consistent with the following six conclusions. First, a genetically functional hybrid fiber can be generated composed of Ad5 fiber amino acids 1-10 fused to Ad37 fiber amino acids 11 -365. Our approach at pseudotyping Ad5 with Ad37 fiber differs from previous studies ). Whereas we replaced the gene coding for Ad5 with Ad5F37, in previous studies the Ad5F37 fusion fiber was provided in trans to fiberless particles in a stable cell line. Genetic replacement of the Ad5 fiber has some advantages over providing the fusion fiber in trans. Because the fusion fiber in our study is under control of the native major late promoter, we expect the fusion fiber to be expressed at similar levels to the native Ad5 fiber. This is unlikely to be the case when fiber is expressed from a CMV promoter in trans. Hence, it is likely that the pseudotyped virus described here is not deficient or limited for fiber incorporation. Our fiber fusion also differs from previous studies ) in that our cloning strategy resulted in the amino acid threonine at position 10, whereas in previous studies this amino acid was aspartic acid. However, because lysine at position 240 likely confers binding to the 50-kDa receptor on Chang C cells (Huang et al., 1999; Wu et al., 2001) , this difference is not of significant concern in the context of comparing our results with previous studies. For purposes of gene therapy, incorporation of an expression cassette coding for EGFP allowed us to study expression of transgenes postinfection rather than Ad binding alone, as has been the main focus of previous studies involving Ad37.
Second, we have shown that the tropism of Ad37 fiber for sialic acid can be conferred upon Ad5 by fiber pseudotyping. Specifically, we demonstrated that Chang C and A549 cells express 2,3-SA and that EGFPNAd5F37 can use 2,3-SA to infect both of these cell types. We reached this conclusion by the observation that infection of Chang C and A549 cells by EGFPNAd5F37 is significantly reduced if the cells are pretreated with the sialic acid hydrolyzing enzyme neuraminidase or with the sialic acid binding lectin Mal II. Mal II treatment of Chang C or A549 cells had no significant effect on infection by EGFPNAd5. The increased infection of neuraminidase-treated A549 cells by EGFPNAd5 (6.6 F 2.5%) has also been observed previously (Arnberg et al., 2000a (Arnberg et al., , 2002 . We conclude that exchanging the fiber of Ad5 with Ad37 is sufficient to redirect tropism from CAR to sialic acid for infection of Chang C and A549 cells. In the case of EGFPNAd5F37 infection of Chang C cells, treatment with neuraminidase had a more significant effect than blocking with Mal II (60% and 26%, respectively). In contrast, EGFPNAd5F37 infection of A549 cells was more reduced by Mal II than by neuraminidase-60% and 37%, respectively. The Chang C result could be explained by the fact that neuraminidase digests at least two different sialic acid linkages (Rogerieux et al., 1993) , whereas Mal II preferentially blocks 2,3-SA-implicating use of other sialic acid linkages in addition to 2,3-SA by EGFPNAd5F37 for cell entry. The A549 result would suggest that infection of these cells by EGFPNAd5F37 is more dependent upon 2,3-SA than other types of sialic acid or that A549 cells express more 2,3-SA than other types of sialic acid. The effect of maackia amurensis agglutinin (MAA) on the binding of wild-type Ad37 was less than that of WGA (Arnberg et al., 2000a (Arnberg et al., , 2002 , arguing in favor of the use of other sialoconjugates, in addition to 2,3-SA. Sendai virus and influenza virus, for example, can use both 2,3-SA and 2,6-SA, albeit at different efficiencies (Stephenson et al., 2003; Suzuki et al., 2001) . While studies involving wild-type Ad37 have demonstrated almost complete ablation of infection by neuraminidase, we did not observe this to be the case for EGFPNAd5F37 despite using approximately three times more neuraminidase than Arnberg et al. (2000a Arnberg et al. ( , 2002 . This suggests that sialic acid may not be the only type of receptor used by EGFPNAd5F37. This has already been indicated for a similar Ad5.GFP.DF/37F that exhibits only a 20% reduction in infection of Chang C cells pretreated with 4-fold more neuraminidase than Wu et al. (2001) . The significant role observed by us for integrin in cellular uptake of EGFPNAd5F37 could be sufficient to explain the residual infection post neuraminidase or Mal II treatment.
Third, we conclude that at least one of the receptors used by EGFPNAd5F37 is associated with proteins on the cell surface, as it is sensitive to protease treatment. Binding of wild-type Ad37 to cells has been observed to be sensitive to a variety of different proteases, including Proteinase K and Bromelain (Arnberg et al., 2000a; Wu et al., 2001 ). While Arnberg et al. (2000a) argued that this is due to the presence of the sialic acid used by Ad37 on glycoproteins as opposed to glycolipids, Wu et al. (2001) argued in favor of Ad37 binding to a neuraminidaseinsensitive 50-kDa protein receptor in Chang C cells. As we did not observe complete ablation of EGFPNAd5F37 infection by neuraminidase despite the use of significantly greater amounts of enzyme than previously used, we cannot rule out the possibility that EGFPNAd5F37 also uses a non-sialic acid protein receptor. However, as stated previously, we believe that incomplete ablation of infection could be reasonably explained by use of integrin by the virus to gain cell entry. It is curious, however, that bromelain treatment exerted a greater effect on Chang C than A549 cells; binding of Ad37 to the 50-kDa receptor was not observed in A549 cells.
Fourth, we conclude that EGFPNAd5F37 uses both integrin and 2,3-SA alone less efficiently for infection than EGFPNAd5 uses integrin and CAR alone. That the pseudotyped EGFPNAd5F37 virus should infect cells less efficiently than the parental EGFPNAd5 virus is expected; an Ad5 virus modified to contain the Ad35 fiber knob domain has been shown to follow a different intracellular trafficking pathway and a significant number of the pseudotyped particles are recycled back to the cell surface (Shayakhmetov et al., 2003) . In addition, Zabner et al. (1999) have shown a greater than 5-fold difference in infectivity of a fiber 17-pseudotyped Ad2 virus when compared with Ad2, and that this difference can be eliminated using methods that overcome the requirements for a fiber receptor. Although integrin is expressed at very low levels in CHO cells (Shayakhmetov et al., 2000) , we found Lec2, which is a subline of CHO, to express aV integrin at levels equivalent to all other cell types used in this study (Fig. 4A) . This sialic acid-deficient cell line is infected more efficiently by EGFPNAd5F37 than Y79 cells, suggesting that integrin plays a greater role than 2,3-SA in cell entry of EGFPNAd5F37. It is likely that the use of integrin by EGFPNAd5F37 is sufficient to explain the incomplete ablation of infection by neuraminidase or Mal II.
Fifth, we conclude that EGFPNAd5F37 cannot use CAR efficiently to infect cells. Wu et al. (2001) have observed the ability of the Ad37 fiber knob to bind CAR immobilized on a PVDF membrane, although infection of Chang C cells by their Ad5.GFP.DF/37F virus was not inhibited by a CAR-blocking antibody. Hence, it is not surprising that we see a small increase in infection of cells that have been transfected by a CAR-expressing plasmid. The Ad5 knob can significantly (approximately 60%) block binding of Ad37 to A549 cells, although CAR binding by Ad37 is inefficient due to the short length of the Ad37 fiber (Wu et al., 2003) . A hybrid fiber similar to that of EGFPNAd5F37 has been shown to mediate infection of CAR-transfected CHO cells by an Ad2 virus containing fiber knob sequences of Ad17 (Zabner et al., 1999) . We observed reasonable levels of Lec2 infection by EGFPNAd5 even in the absence of CAR transfection. Although using an antibody to detect human CAR leads us to the conclusion that Lec2 cells are CAR-deficient, this observation may be erroneous if there is no cross-reactivity between the antihuman CAR antibody and Chinese hamster CAR. Previous studies also did not observe CAR expression on CHO cells, but they also used an antibody against human CAR (Shayakhmetov et al., 2000) . We did, however, observe cross-reactivity with rat CAR in RPE-J cells (Fig. 6A) .
Sixth, we conclude that disruption of tight junctions between RPE-J cells enhances EGFPNAd5F37 infection. EDTA has been shown to increase permeability of tight junctions in cultured rat RPE cells (Rezai et al., 1997) . Because experiments described above indicate that EGFPNAd5F37 uses 2,3-SA and not CAR to gain cell entry and that both CAR and SA are expressed on RPE-J cells, it is likely that EGFPNAd5F37 has enhanced access to the sialic acid post disruption of the tight junctions. EDTA enhancement of adenovirus serotype 5 infection has previously been observed in a polarized tracheobronchial epithelial cell line, in which CAR is expressed in association with the tight junction protein ZO-1 (Cohen et al., 2001) . The circumferential distribution of sialic acid (WGA staining; Fig. 6B ) suggests that as for Ad5 binding of CAR, treatment with EDTA possibly increases accessibility of sialic acid for binding by EGFPNAd5F37. This observation may have significance in the treatment of diseases such as diabetic retinopathy, which is the leading cause of blindness in middle-aged and older people (Javitt et al., 1994) . Specifically, the most common cause of vision loss in diabetes is due to macular edema (Moss et al., 1998) , a pathology that results as a direct consequence of blood -retinal barrier breakdown. Increased susceptibility of RPE by EGFPNAd5F37 during tight junction disruption may offer a potential advantage to deliver therapeutic transgenes to the RPE using Ad5F37 vectors.
While we have demonstrated the significant role of sialic acid in infection by EGFPNAd5F37, we have not excluded a role for the 50-kDa receptor. However, it should be noted that whereas Wu et al. (2001) determined that Ad37 binds the 50-kDa receptor in an overlay blot assay, CAR was also shown to bind Ad37 in this same experiment. However, CAR has been shown independently not to be used by Ad37 for infection of cells in culture (Arnberg et al., 2000a; Wu et al., 2001 Wu et al., , 2003 . Hence, it is possible that similar observations might be made for the 50-kDa receptor in future studies.
In summary, we have shown that it is possible to genetically pseudotype Ad5 with the Ad37 fiber. Although the resulting virus uses 2,3-SA as a cellular receptor, this may not be the only receptor the virus can use. Although infection of cells is sensitive to protease treatment, the alternate receptor(s) used by EGFPNAd5F37 does not include CAR. When present alone, integrin is more efficient than SA for entry of EGFPNAd5F37. Infection can be enhanced by exposure of sialic acid at tight junctions by EDTA. These data have relevance for the further design of Ad vectors for gene therapy and possible use in the treatment of diseases involving the blood -retinal barrier.
Materials and methods
Recombinant adenovirus constructs
Ad5 virus expressing Ad37 fiber was generated via genetic modification of the Ad5 genome cloned in pAdEasy-1 (He et al., 1998) . In brief, pAdEasy-1 was digested with SpeI and PacI, and the 6211-bp fragment containing the fiber gene was cloned into pBSx (Cox et al., 1993) , resulting in p6.2FIB. Ad5 nt 32 744 -32 872 were PCR amplified using primers Ad32744F (cccaagcttgccacatcctcttacac) and Ad32872R (tggggctatactactgaatg), yielding a 128-bp product that was digested with HindIII and MfeI, and the resulting 83 bp product gel excised and cloned into HindIII and MfeI digested pLitmus38 (New England Biolabs) resulting in pLITSF. Wild-type Ad37, strain GW(76-190026) , was obtained from the American Type Culture Collection (ATCC), used to infect 911 cells (Fallaux et al., 1996) , and the viral lysate was pronase treated and DNA precipitated with ethanol. The Ad37 fiber gene (at +49) including 63 bp upstream of the Ad37 fiber stop codon was PCR amplified using primers with an EcoRI (underlined) and NdeI site (bold) FIB17F, cccgaattcatatggctacgcgcggaatc, and FIB17/ 37R containing an XbaI site (bold), ccctctagagctggtgtaaaaattcaataaaga; PCR product digested with EcoRI and XbaI, and cloned into EcoRI and XbaI digested pIRES1neo (Clontech) resulting in pFIB37pA-a plasmid containing the majority of the Ad37 fiber gene with its own poly A signal followed by the bovine growth hormone polyadenylation signal (BGH pA). The Ad37 fiber and BGH pA were subcloned into pLITSF, resulting in pFIB37pASF, which was digested with NdeI and MfeI, and cloned into NdeI and MfeI digested p6.2FIB, resulting in p6.2FIB37pA. The SpeI to PacI modified fiber-containing fragment was exchanged with the 6.2-kb Ad5 fiber-containing fragment in pAdEasy-1, resulting in pAd5F37 (Fig. 1A) . The region containing the modified fiber gene was confirmed by sequencing. The sequencing data predicted expression of a 40-kDa fusion fiber protein con-sisting of the first 17 amino acids of the Ad5 fiber followed by amino acids 18 -365 of Ad 37 fiber (Fig. 1B) . To introduce a GFP expression cassette into the pseudotyped virus, an AseISspI fragment of pEGFP-C1 (Clontech) was cloned into EcoRV-digested pShuttle (He et al., 1998) , in the antisense orientation with respect to the E1 enhancer/promoter, resulting in pShEGFPN.
Production of recombinant adenovirus pShEGFPN was digested with PmeI and recombined with either pAdEasy-1 or pAd5F37 by co-transformation of Escherichia coli BJ5183 as previously described (Cashman et al., 2002) . The resulting plasmids pEGFPNAd5 and pEGFPNAd5F37 were transformed into E. coli XL1-Blue (Stratagene) for large-scale plasmid amplification. The recombinant adenovirus plasmids were digested with PacI and transfected into 911 cells to generate virus (Cashman et al., 2002) and purified using the Adenopure purification kit (Puresyn, Inc) followed by dialysis into 1% sucrose in PBS by centrifugation through a 15-ml filter device (50 K NMWL; Millipore Corp). Viral preps were concentrated to a volume of approximately 1 ml with an A 260 of 0.62-1.24. The pseudotyped virus is hereafter called EGFPNAd5F37 and the control parental Ad5 based virus as EGFPNAd5.
Cell lines
Chang C, A549, Y79, RPE-J, and CHO (Lec 2) cell lines were obtained from ATCC. Cell culture reagents were purchased from Invitrogen Life Technologies. Chang C, A549, and 911 (Fallaux et al., 1996) cells were maintained in DMEM and 10% FBS. RPE-J cells were maintained in DMEM and 4% FBS with 0.1 mM nonessential amino acids. Y79 cells were maintained in RPMI 1640 with L-glutamine (2 mM), sodium pyruvate (1 mM), and 15% FBS. CHO (Lec2) cells were maintained in aMEM with 10% FBS.
Western blots
911 cells were infected at a multiplicity of infection (MOI) of 250 and 2500 by EGFPNAd5 and EGFPNAd5F37, respectively. Thirty-six hours later, cells were harvested by scraping cells off the culture plate, rinsed twice with PBS, and lysed in 50 mM Tris -HCl pH 8.0, 150 mM NaCl, 0.1% SDS, 1.0% Triton X-100 containing leupeptin (10 Ag/ml), aprotinin (10 Ag/ml), and PMSF (0.1 mM). Lysate from EGFPNAd5-infected (5 Ag) or EGFPNAd5F37-infected (10 Ag) cells was boiled for 3 min and loaded onto a 12% Tris-Glycine polyacrylamide gel (BMA). To determine trimerization of the fiber, samples were loaded without boiling. The fiber protein was detected using the monoclonal antibody, Ab-4 (Clone 4D2, NeoMarkers). Secondary detection was performed using an HRP-conjugated goat anti-mouse antibody (Jackson ImmunoResearch). For the detection of aV Integrin, 20-Ag protein was electrophoresed as described above. Integrin (aV) was detected using a monoclonal antibody specific to amino acids 609-722 of human CD51 (clone 21, BD Transduction Labs). h-Actin was detected using a monoclonal antibody that detects a 15 amino acid sequence at the N-terminus of h-actin (clone AC-15, Sigma). Secondary detection was achieved with an HRP-conjugated goat anti-mouse antibody.
Neuraminidase treatment
2.5 Â 10 5 Chang C or A549 cells were suspended in a volume of 200 Al (40 mU) Vibrio cholerae neuraminidase (Sigma) and incubated at 37 jC for 1 h. Cells were washed with 1Â PBS and incubated with virus in DMEM without FBS at an MOI of 1240 (EGFPNAd5) or 18 800 (EGFPNAd5F37) at 4 jC for 30 min. The unbound virus was removed by washing the cells with 1Â PBS, and cells were transferred to 24-well plates for 48 h at 37 jC and 5% CO 2 . Different MOIs were used for each virus in this and successive experiments as use of the same MOI would have resulted in too little infection by EGFPNAd5F37 or too much infection by EGFPNAd5.
Lectin blocking
2.5 Â 10 5 Chang C or A549 cells were suspended in 250
Ag/ml maackia amurensis lectin II (Mal II; Vector Laboratories) and incubated at 4 jC for 30 min. Cells were washed and incubated with virus as described above for neuraminidase treatment.
Protease treatment
1 Â 10 7 Chang C or A549 cells were suspended in 200
Al (40 Ag) proteinase K (Invitrogen), 50 mU bromelain (Sigma), or PBS, and incubated at 37 jC for 30 min (Chang C) or 1 h (A549). Cells were washed with 1Â PBS and 2.5 Â 10 5 cells were plated per well of 24-well plates and incubated with virus in DMEM without FBS at an MOI of 1240 (EGFPNAd5) and 16 800 (EGFPNAd5F37) at 37 jC for 6 h. The unbound virus was removed by washing cells with 1Â PBS, and the cells were incubated for a further 42 h at 37 jC and 5% CO 2 .
Analyses of CAR and sialic acid expression CAR expression was detected by FACS analysis of cells incubated with RmcB antibody (provided kindly by Jeffrey Bergelson) (Hsu et al., 1988) followed by a donkey antimouse antibody conjugated with FITC. Sialic acid was detected by incubating cells with either FITC-conjugated wheat germ agglutinin (WGA) or biotinylated Mal II followed by FITC-conjugated streptavidin (10 Ag/ml; Vector Laboratories) at 4 jC for 20 min. Cells were fixed with 4% paraformaldehyde and either analyzed by FACS or visualized directly with a Nikon TS100 microscope with a short-arc mercury lamp and a FITC filter. Images were captured using CoolSnap software.
Infection of Y79 and Lec2 cells 2.5 Â 10 5 cells were suspended in 200 Al RPMI with 2% FBS (Y79) or aMEM without FBS (Lec2) and infected with either EGFPNAd5 (MOI of 1240) or EGFPNAd5F37 (MOI of 12 000 or 48 000; Fig. 4 ). Cells were incubated with virus at 37 jC for 1 h, washed, and plated for a further 23-h incubation at 37 jC and 5% CO 2 before FACS analyses.
Transfection of CHO cells with CAR-expressing plasmid
Plasmid-expressing human CAR (hCAR) under the control of a CMV promoter was kindly provided by Jeffrey Bergelson. 5 Â 10 6 CHO (Lec2) cells were mixed with 3.5 Ag of plasmid expressing beta galactosidase -pCMVh (Clontech) or hCAR and electroporated with 1 pulse of 190 V over 7 ms using an ECM 830 (BTX) electroporator. 2.5 Â 10 5 cells were plated per well of a 24-well plate. After 6-h incubation at 37 jC and 5% CO 2 , the cells were infected with either EGFPNAd5 or EGFPNAd5F37 at an MOI of 2480 and 12 800, respectively. The infection was allowed to proceed for 24 h before FACS analyses.
Effect of EDTA treatment on infection
5 Â 10 5 RPE-J cells were treated with 2.5 mM EDTA in PBS at 37 jC for 30 min. Cells were washed with PBS and incubated with either EGFPNAd5 at an MOI of 1480 or EGFPNAd5F37 at an MOI of 6400 at 37 jC for 2 h. Unbound virus was removed by washing the cells with 1Â PBS and the cells were incubated for a further 42 h at 37 jC and 5% CO 2 before FACS analyses.
FACS analyses
Cells were harvested with 1Â trypsin-EDTA, rinsed, and suspended in 1Â PBS to a concentration of 1 Â 10 6 cells/ ml. FITC-and EFGP-positive cells were detected using a FACScan (Becton-Dickinson) equipped with a 15 MW argon laser (488 nm) activation source and a 530 F 15 nm filter. Results were analyzed using CellQuest Pro software (Becton-Dickinson).
Statistical analyses
Except where otherwise stated, all experiments were performed three times in duplicate. Error bars represent standard deviations from the mean. Positive errors only are shown. Where absent, error bars were significantly smaller than the resolution of the graph. Where appropriate, significance was calculated using the Student's t test.
